Navigation Links
Reprogrammed Cells Reduce Parkinson's Symptoms
Date:4/7/2008

Rodent studies could lead to therapeutic applications in humans, researchers say

MONDAY, April 7 (HealthDay News) -- Transplanted neurons derived from reprogrammed adult skin cells successfully integrated into the brains of fetal mice and reduced symptoms of a Parkinson's disease-like condition in adult rats, say U.S. researchers.

"This is the first demonstration that reprogrammed cells can integrate into the neural system or positively affect neurodegenerative disease," study author Marius Wernig, a postdoctoral researcher at the Whitehead Institute for Biomedical Research in Cambridge, Mass., said in a prepared statement.

The induced pluripotent stem (IPS) cells were created by reprogramming adult skin cells using retroviruses that expressed four genes (Oct4, Sox2, c-Myc and Klf4) into the cells' DNA. The IPS cells were then differentiated into neural precursor cells and dopamine neurons.

In one experiment, the neural precursor cells were transplanted into the brains of mouse embryos. When the researchers analyzed the mice nine weeks after birth, they found the transplanted cells had formed clusters at the area they'd been injected and then migrated into surrounding brain tissue.

The researchers also found the migrating neural precursor cells had differentiated into several subtypes of neural cells and had functionally integrated into the brain.

In another experiment, differentiated dopamine neurons were grafted into the brains of rats in which the dopamine-producing neurons on one side of the brain had been destroyed. This is a model of Parkinson's disease in humans, which is caused by insufficient levels of dopamine.

Four weeks after the surgery, eight of the nine rats that received the dopamine neuron transplants showed improvement. Eight weeks after transplantation, the dopamine neurons had extended into the surrounding brain tissue.

The study was published in this week's online issue of the Proceedings of the National Academy of Sciences.

While this work shows promise, much more research needs to be done before there's any likelihood that it will lead to new treatments for humans.

More information

We Move has more about Parkinson's disease.



-- Robert Preidt



SOURCE: Whitehead Institute, news release, April 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Identification of dopamine mother cells could lead to future Parkinsons treatments
2. Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrigs disease
3. Nanomachine Releases Anticancer Drugs Inside Cells
4. Fetal Cells Detected in Mothers Blood Years After Donor Egg Pregnancies
5. Fasting Before Chemo Protects Healthy Cells
6. UCLA researchers design nanomachine that kills cancer cells
7. Scientists Uncover How HIV Hides Inside Cells
8. Stem cells from hair follicles may help grow new blood vessels
9. Researchers Create Protective Sac for Growing Stem Cells
10. Cells from the Research Institute of the MUHC on the road to China
11. Scientists learn whats up with a class of retinal cells in mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reprogrammed Cells Reduce Parkinson's Symptoms 
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: